MIFH
DGX icon

Migdal Insurance & Financial Holdings’s Quest Diagnostics DGX Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-360
Closed -$45K – 533
2022
Q3 		$45K Hold
360
– – ﹤0.01% 316
2022
Q2 		$48K Buy
360
+32
+10% +$4.36K ﹤0.01% 373
2022
Q1 		$46K Sell
328
-218
-40% -$30.4K ﹤0.01% 446
2021
Q4 		$94K Buy
546
+43
+9% +$6.54K ﹤0.01% 369
2021
Q3 		$73K Sell
503
-116
-19% -$17K ﹤0.01% 398
2021
Q2 		$82K Buy
619
+137
+28% +$17.9K ﹤0.01% 428
2021
Q1 		$62K Buy
482
+156
+48% +$19.2K ﹤0.01% 522
2020
Q4 		$39K Buy
+326
New +$39.7K ﹤0.01% 554
2018
Q4 		– Sell
-975
Closed -$105K – 726
2018
Q3 		$105K Sell
975
-101
-9% -$11.1K ﹤0.01% 584
2018
Q2 		$118K Buy
1,076
+1,064
+8,867% +$111K ﹤0.01% 497
2018
Q1 		$1K Buy
+12
New +$1.23K ﹤0.01% 638
2017
Q1 		– Sell
-4,963
Closed -$456K – 464
2016
Q4 		$456K Buy
+4,963
New +$428K 0.01% 208

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Migdal Insurance & Financial Holdings's DGX Position: Q4 2022 in Review

Migdal Insurance & Financial Holdings sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 360 shares — an estimated $45K sold.

Migdal Insurance & Financial Holdings first reported a position in DGX in Q4 2016 and held it in 12 quarters. The position peaked at $456K in Q4 2016. 880 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 360 Quest Diagnostics shares in Q4 2022, an estimated $45K.
  • Migdal Insurance & Financial Holdings first reported a position in Quest Diagnostics in Q4 2016 and held it in 12 quarters.
  • Migdal Insurance & Financial Holdings's Quest Diagnostics position peaked at $456K in Q4 2016.
  • 880 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2022, filed 23 Jan 2023.